VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer

類似資料

• Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
  著者:: Wajja, A, 等
  出版事項: (2024)
• Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
  著者:: Zhang, C, 等
  出版事項: (2023)
• Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
  著者:: Charlotte Davis, 等
  出版事項: (2024-06-01)
• Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
  著者:: Cheng Zhang, 等
  出版事項: (2023-06-01)
• Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
  著者:: Adam Berg, 等
  出版事項: (2021-10-01)